| http://www.w3.org/ns/prov#value | - The summer was an especially lively time, with Hyperion Therapeutics, Durata Therapeutics and Tesaro debuting on the public markets, and Kythera Bioparmaceuticals and Merrimack Pharmaceuticals following not long after.But the data also shows a smaller number of funding rounds???for a smaller total value???for the first three quarters of last year compared to the same period in 2011.
|
